Published in Eur Heart J on November 21, 2008
The extended granin family: structure, function, and biomedical implications. Endocr Rev (2011) 1.43
Catestatin: a multifunctional peptide from chromogranin A. Regul Pept (2010) 1.05
Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling. Pflugers Arch (2013) 0.99
Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart. Cell Mol Neurobiol (2010) 0.97
Biological function and clinical relevance of chromogranin A and derived peptides. Endocr Connect (2014) 0.94
Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study. PLoS One (2012) 0.90
Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384)). Cell Tissue Res (2010) 0.87
A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium. Cardiovasc Res (2011) 0.87
The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes. FASEB J (2012) 0.85
Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart. Regul Pept (2010) 0.85
The surging role of Chromogranin A in cardiovascular homeostasis. Front Chem (2014) 0.84
Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction. PLoS One (2015) 0.80
Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci (2016) 0.77
Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties. PLoS One (2012) 0.76
Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway. Hypertension (2016) 0.75
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease. Oncoimmunology (2016) 0.75
Prognostic value of circulating chromogranin A levels in acute coronary syndrome. Eur Heart J (2009) 0.75
Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure. Curr Heart Fail Rep (2017) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Universal definition of myocardial infarction. Eur Heart J (2007) 9.04
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
The chromogranin-secretogranin family. N Engl J Med (2003) 4.28
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation (2002) 3.79
Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest (2005) 2.19
Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J (2002) 1.98
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J (2007) 1.81
Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation (2003) 1.75
New concept in echocardiography: harmonic imaging of tissue without use of contrast agent. Lancet (1998) 1.64
Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med (1986) 1.58
Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol (2007) 1.23
Secretion from chromaffin cells is controlled by chromogranin A-derived peptides. Proc Natl Acad Sci U S A (1988) 1.15
Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med (1984) 1.14
Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation (1990) 1.14
Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut (1996) 1.11
Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem (1989) 1.10
A comparison between three commercial kits for chromogranin A measurements. J Endocrinol (2003) 1.08
Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction. Am J Med (2003) 1.03
Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J (2004) 0.99
Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem (2001) 0.98
Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem (1990) 0.98
Chromogranin A correlates with norepinephrine release rate. Life Sci (1992) 0.98
Chromogranins--new sensitive markers for neuroendocrine tumors. Acta Oncol (1989) 0.98
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. Am Heart J (2006) 0.96
The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept (1992) 0.95
Relationship between renal function and blood level of chromogranin A. Ren Fail (2001) 0.93
Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol (1991) 0.89
Regulation of endothelial cell shape and barrier function by chromogranin A. Ann N Y Acad Sci (2002) 0.87
Spectrum of acute coronary syndromes: history and clinical presentation in relation to sex and age. Cardiology (2004) 0.86
Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. Acta Physiol Scand (1994) 0.83
Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart. Regul Pept (2003) 0.83
Chromogranin A-activated microglial cells induce neuronal apoptosis. Ann N Y Acad Sci (2002) 0.78
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest. N Engl J Med (2015) 6.58
Prevention and early detection of vascular complications of diabetes. BMJ (2006) 4.14
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation (2002) 3.79
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology (2003) 3.59
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart (2012) 3.36
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int (2008) 3.27
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation (2002) 2.85
Contextual determinants of alcohol consumption changes and preventive alcohol policies: a 12-country European study in progress. Subst Use Misuse (2011) 2.81
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab (2009) 2.76
Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise. J Physiol (2005) 2.75
High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart (2013) 2.58
Expert consensus on peri-operative myocardial injury screening in noncardiac surgery: A literature review. Eur J Anaesthesiol (2021) 2.57
Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab (2006) 2.52
Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab (2012) 2.46
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int (2004) 2.42
Bicuspid aortic valve leaflet morphology in relation to aortic root morphology: a study of 300 patients undergoing open-heart surgery. Eur J Cardiothorac Surg (2011) 2.41
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology (2009) 2.39
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol (2003) 2.34
Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med (2004) 2.23
Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest (2012) 2.21
[Long-term prognosis in myocardial infarction worse than expected. A study of a hospital-treated population of infarction patients gives new perspectives]. Lakartidningen (2008) 2.04
Surgical repair of post infarction ventricular septal defects: a national experience. Eur J Cardiothorac Surg (2005) 1.95
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med (2003) 1.91
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol (2004) 1.88
Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol (2005) 1.84
Whey and casein labeled with L-[1-13C]leucine and muscle protein synthesis: effect of resistance exercise and protein ingestion. Am J Physiol Endocrinol Metab (2010) 1.82
Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation (2011) 1.78
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis (2003) 1.74
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev (2004) 1.74
Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation. Chest (2011) 1.72
Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes (2005) 1.71
Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study. Chest (2005) 1.70
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes (2002) 1.69
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol (2013) 1.65
Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study. Ann Emerg Med (2005) 1.63
Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol (2006) 1.63
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J (2007) 1.63
Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am J Hypertens (2009) 1.61
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab (2006) 1.61
Adiponectin and lipoprotein particle size. Diabetes Care (2009) 1.60
Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes (2004) 1.59
International comparison of treatment and long-term outcomes for acute myocardial infarction in the elderly: Minneapolis/St. Paul, MN, USA and Goteborg, Sweden. Eur Heart J (2013) 1.56
A farewell to body-mass index? Lancet (2005) 1.54
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab (2007) 1.49
Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study. Intensive Care Med (2012) 1.48
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart (2012) 1.47
Strenuous physical exercise adversely affects monocyte chemotaxis. Thromb Haemost (2010) 1.45
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol (2008) 1.45
Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? Am Heart J (2006) 1.45
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiology (2012) 1.44
Low mortality and low rate of perceived and documented arrhythmias after Cox maze III surgery for atrial fibrillation. Pacing Clin Electrophysiol (2013) 1.39
Diagnostic and referral delay in patients with aortic stenosis is common and negatively affects outcome. Scand Cardiovasc J (2007) 1.39
Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart (2012) 1.38
Five-year mortality for stable angina in a medical practice study and a randomized trial. Scand Cardiovasc J (2002) 1.38
Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials (2006) 1.38
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes (2007) 1.37
Diagnostic utility of a single-epitope sandwich B-type natriuretic peptide assay in stable coronary artery disease: data from the Akershus Cardiac Examination (ACE) 1 Study. Clin Biochem (2012) 1.36
Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol (2009) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients. Eur J Endocrinol (2006) 1.34
Assessment of early diabetic renal changes with hyperpolarized [1-(13) C]pyruvate. Diabetes Metab Res Rev (2013) 1.34
B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med (2003) 1.31
Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J (2004) 1.31
Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry (2011) 1.31
Cardiovascular disease and insulin-like growth factor I. Circulation (2002) 1.30
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev (2011) 1.30
Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med (2008) 1.27
Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes (2012) 1.27
Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol (2012) 1.25
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J (2006) 1.24
Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol (2005) 1.23
Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol (2011) 1.21
Circulating microRNAs and aerobic fitness--the HUNT-Study. PLoS One (2013) 1.20
Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med (2004) 1.19
Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol (2009) 1.18
Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2012) 1.17
Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology (2007) 1.16
Ghrelin and its relationship to growth hormones during normal pregnancy. Clin Endocrinol (Oxf) (2005) 1.15
Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med (2010) 1.14
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J (2003) 1.14
Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women. J Appl Physiol (1985) (2008) 1.13
Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc Diabetol (2011) 1.13
Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab (2007) 1.12
Elevated levels of high-molecular-weight adiponectin in type 1 diabetes. J Clin Endocrinol Metab (2008) 1.12
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes (2005) 1.10
Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care (2009) 1.10